CARLSBAD, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Alphatec Spine, Inc., (Nasdaq:ATEC), a global provider of
spinal fusion technologies, announced today that the Company has launched its new Arsenal Deformity Adolescent Idiopathic Scoliosis
(AIS) System and has successfully completed initial patient cases. The limited release further expands the Company’s Arsenal
Spinal Fixation System and targets the $650M U.S. deformity spine market.
The Arsenal AIS System gives surgeons a complete solution to address complex deformity pathologies, including unique uniplanar
screws, which enable easier screw positioning and rod placement through a tulip that has 360 degrees of rotation, while restricting
motion in the medial/lateral plane for derotation correction. Additionally, the AIS system includes a wide variety of
low-profile implants providing a better anatomical fit and increased ability to address patient pathologies, ergonomically designed
instrumentation to improve surgical efficiency and comfort during complex surgeries, and proven biomechanical strength necessary to
achieve a solid fusion.
Terry Rich, Alphatec Spine’s Chief Executive Officer commented, “With the launch of our differentiated AIS Deformity System we
are able to compete directly with the market leaders in complex spine and it opens up a new segment for us in pediatric
procedures. This unique system extends our Arsenal platform and provides surgeons with easy-to-use, differentiated surgical
tools for corrective maneuvers to better treat adolescent patients who are diagnosed with idiopathic scoliosis. These
successful initial patient cases demonstrate ATEC’s ongoing commitment to developing innovative solutions that are targeted at
improving overall patient outcomes and surgeon experience. The Arsenal AIS system gives us the opportunity to gain greater
share in the deformity market and to benefit a vast number patients who are suffering today.”
Dr. Sheldon St. Clair, a pediatric orthopedic surgeon, and Dr. John Birknes, a pediatric neurosurgeon, co-directors of the
Spine Program at the Children's Hospital of the King’s Daughters in Virginia, have partnered to treat pediatric
spine deformities and performed the first deformity correction using the Arsenal AIS system. The patient was a skeletally immature
13-year-old with a hypokyphotic 49-degree thoracic scoliosis. Drs. St. Clair and Birknes performed the surgery using the
Arsenal uniplanar implants and cobalt-chromium alloy rods on a long construct across 9 levels from thoracic vertebrae T3 to
T12. Post-surgery, the patient’s thoracic curve has been eliminated, appropriate kyphosis has been restored, and the
patient’s rib hump is no longer present.
“The entire Arsenal Deformity AIS set is fantastic, but the shining star is the ability to spin the uniplanar bodies independent
of the screw shank, which allows surgeons to achieve optimal fixation and placement of the pedicle screws,” said Dr. St. Clair.
“This unique feature enables the tulips to be placed at the perfect height and orientation to accept the rod and correct the
deformity. The slotted reduction towers are used both to reduce the rod into the tulips as well as to perform vertebral
column manipulation to correct the spine in three planes of deformity. The reduction towers and transverse links are designed
to be attached and removed with ease. The Arsenal AIS system provides strong, reliable implants, and two choices of
cobalt chrome rods, enabling the surgeon to obtain excellent spinal deformity correction, which improves quality of life for
the patient both now and for the future.”
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC), is a medical device
company that designs, develops, manufactures and markets spinal fusion technology products and solutions for the treatment of
spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Company's mission is to improve
lives by delivering advancements in spinal fusion technologies. The Company and its affiliates market products in the U.S. via a
direct sales force and independent distributors.
Additional information can be found at www.alphatecspine.com.
Forward Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations
and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in
the forward-looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business
conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various
factors. Forward-looking statements include the Company's ability to achieve profitable growth; the Company’s ability to
achieve both domestic and international growth and future profitability. The words "believe," "will," "should," "expect,"
"intend," "estimate" and "anticipate," variations of such words and similar expressions identify forward-looking statements, but
their absence does not mean that a statement is not a forward-looking statement. The important factors that could cause
actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but
are not limited to; the uncertainty of success in developing new products or products currently in Alphatec Spine's pipeline within
forecast timeframes, or at all, including without limitation the products discussed in this press release; the Company’s ability to
compete directly with the market leaders in complex spine and open up a new segment for the Company in pediatric procedures; the
Company’s ability to gain greater share in the deformity market and to benefit a vast number patients in such market; the
acceptance of Alphatec Spine's products by the surgeon community, including without limitation the products discussed in this press
release; and Alphatec Spine's ability to develop and expand its U.S. revenues. Please refer to the risks detailed from
time to time in Alphatec Spine's SEC reports, including its Annual Report Form 10-K, as well as other filings on Form 10-Q and
periodic filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events, or otherwise, unless required by law.
CONTACT: Investor/Media Contact: Christine Zedelmayer Investor Relations Alphatec Spine, Inc. (760) 494-6610 czedelmayer@alphatecspine.com
